Correlation Between Cullinan Oncology and Oric Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Oric Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Oric Pharmaceuticals.
Diversification Opportunities for Cullinan Oncology and Oric Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cullinan and Oric is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Oric Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Oric Pharmaceuticals
Given the investment horizon of 90 days Cullinan Oncology is expected to generate 3.43 times less return on investment than Oric Pharmaceuticals. But when comparing it to its historical volatility, Cullinan Oncology LLC is 1.38 times less risky than Oric Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Oric Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 402.00 in Oric Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 557.00 from holding Oric Pharmaceuticals or generate 138.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Oric Pharmaceuticals
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Oric Pharmaceuticals |
Cullinan Oncology and Oric Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Oric Pharmaceuticals
The main advantage of trading using opposite Cullinan Oncology and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. RenovoRx | Cullinan Oncology vs. Tempest Therapeutics |
| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |